Capital One Initiates Coverage On GlycoMimetics With Overweight Rating, Announces Price Target of $12
Capital One Initiates Coverage On GlycoMimetics With Overweight Rating, Announces Price Target of $12
Capital One 以增持評級啓動對 GlycoMimetics 的報道,宣佈目標股價爲12美元
Capital One analyst Zegbeh Jallah initiates coverage on GlycoMimetics (NASDAQ:GLYC) with a Overweight rating and announces Price Target of $12.
Capital One分析師Zegbeh Jallah以增持評級開始對GlycoMimetics(納斯達克股票代碼:GLYC)進行報道,並宣佈目標股價爲12美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。